查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1513632

全球哺乳动物细胞银行市场：产业分析、规模、占有率、成长、趋势、预测，2024-2033 年

Mammalian Cell Banking Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 251 Pages | 商品交期: 2-5个工作天内

价格
简介目录

本报告提供了有关全球哺乳动物细胞银行市场的综合报告。它全面评估了关键市场动态，包括市场驱动因素、趋势、机会和课题，并提供了有关市场结构的详细见解。

重要见解

  • 哺乳动物细胞银行市场规模（2024 年）：4.965 亿美元
  • 预计市值（2033年）：16亿美元
  • 全球市场成长率（2024-2033年复合年增长率）：13.9%

哺乳动物细胞银行市场 - 报告范围：

哺乳动物细胞库在生物製药和生物技术产业中发挥重要作用，为各种应用（包括药物开发、疫苗生产和再生医学）的细胞系提供稳定的储存库。该市场为製药公司、学术机构、研究机构和合约研究组织 (CRO) 提供服务，提供包括细胞系表征、储存和分销在内的广泛服务。

市场成长动力：

全球哺乳动物细胞库市场由几个关键因素推动，包括对生物製药的需求增加、对细胞疗法的投资增加以及提高细胞系稳定性和生产力的生物技术的进步。慢性病的盛行率不断上升以及对生物製品高效生产的需求进一步推动了市场的扩张。此外，冷冻保存技术和品质控制措施的创新透过确保储存细胞系的完整性和活力，有助于市场扩张。

市场限制因素：

儘管成长前景广阔，但哺乳动物细胞银行市场面临着监管合规性、细胞系采购的道德考虑以及长期储存过程中保持细胞系真实性和纯度的复杂性等课题。管理细胞银行实践的严格法规以及持续监控以防止污染的需要给市场参与者带来了营运课题，影响了可扩展性和成本效率。

市场机会：

由于个人化医疗、细胞治疗和干细胞研究的新兴应用，哺乳动物细胞库市场提供了巨大的成长机会。将自动化和机器人技术整合到细胞银行设施中，可提高营运效率并减少人为错误，从而优化细胞繫管理和储存。此外，生物製药公司、学术机构和 CRO 之间的策略联盟将促进知识交流并加速细胞银行技术的创新。

本报告解决的关键问题

  • 推动全球哺乳动物细胞银行市场成长的关键因素是什么？
  • 哪些应用和治疗领域正在推动哺乳动物细胞库服务的需求？
  • 科技进步如何改变哺乳动物细胞银行市场的竞争格局？
  • 谁是哺乳动物细胞银行市场的主要参与者？ 他们保持市场领先地位的策略是什么？
  • 全球哺乳动物细胞银行市场的新趋势和未来前景是什么？

目录

第1章 内容提要

第2章 市场概况

  • 市场范围/分类
  • 市场定义/范围/限制
  • 包容与排除

第三章 主要市场趋势

  • 影响市场的主要趋势
  • 发展/创新趋势

第 4 章关键成功因素

  • 管道评估
  • 价值链分析
  • 各大厂商主要促销策略
  • 监管状况
  • PESTLE分析
  • 波特的分析

第5章 市场背景

  • 宏观经济因素
  • 预测变量 - 相关性和影响
  • 市场动态

第 6 章 COVID-19 危机 - 影响评估

  • COVID-19 与影响分析
    • 依细胞
    • 依用途
    • 依最终用户
    • 依地区
  • 2024年市场情景

第七章全球哺乳动物细胞银行市场需求金额或规模（百万美元）分析

  • 2019-2023 年历史市值（百万美元）分析
  • 2024-2033 年当前和未来市场价值（百万美元）预测
    • 同比增长趋势分析
    • 绝对美元机会分析

第八章全球哺乳动物细胞银行市场分析：依细胞分类

  • 简介/主要发现
  • 2019-2023 年历史市场规模（百万美元）分析（依电池）
  • 当前和未来市场规模（百万美元）分析和预测（依电池），2024-2033 年
    • CHO
    • BHK
    • NS0
    • YB2/0・P2/0
    • HEK293/衍生物
    • 海拉
  • 市场吸引力分析：依电池

第九章全球哺乳动物细胞银行市场分析：依技术分类

  • 简介/主要发现
  • 2019-2023 年历史市场规模（百万美元）分析（依技术）
  • 2024-2033 年当前和未来市场规模（百万美元）分析和预测（依技术）
    • TEP
    • IEP
    • SEP
  • 市场吸引力分析：依技术分类

第10章全球哺乳动物细胞银行市场分析：依应用分类

  • 简介/主要发现
  • 2019-2023 年历史市场规模（百万美元）分析（依应用）
  • 2024-2033 年当前和未来市场规模（百万美元）分析和预测（依应用）
    • 微型断路器
    • W.C.B.
    • 结束时间
    • 研发CB
  • 市场吸引力分析：依应用分类

第十一章全球哺乳动物细胞银行市场分析：依最终用户

  • 简介/主要发现
  • 2019-2023 年历史市场规模（百万美元）分析（依最终用户）
  • 当前和未来市场规模（百万美元）分析和预测（依最终用户），2024-2033 年
    • 学术研究机构
    • 生物製药公司
    • CRO
  • 市场吸引力分析：依最终用户

第十二章全球哺乳动物细胞银行市场分析：依地区

  • 简介/主要发现
  • 2019-2023 年历史市场规模（百万美元）分析（依地区）
  • 2024-2033 年当前和未来市场规模（百万美元）分析和预测（依地区）
    • 北美
    • 拉丁美洲
    • 欧洲
    • 东亚
    • 南亚
    • 大洋洲
    • 中东/非洲
  • 市场吸引力分析：依地区

第十三章北美哺乳动物细胞银行市场分析

第十四章拉丁美洲哺乳动物细胞银行市场分析

第十五章欧洲哺乳动物细胞银行市场分析

第十六章南亚哺乳动物细胞银行市场分析

第十七章东亚哺乳动物细胞银行市场分析

第十八章大洋洲哺乳动物细胞银行市场分析

第十九章中东与非洲哺乳动物细胞银行市场分析

第二十章市场结构分析

  • 依公司层级划分的市场分析
  • 主要企业市场占有率分析（%）
  • 市场存在分析

第21章 竞争分析

  • 比赛仪表板
  • 竞争标桿
  • 衝突详情
    • Eurofins DiscoverX Corporation
    • Merck KGaA
    • Sartorius Stedim BioOutsource Limited.
    • Charles River Laboratories
    • Altogen Labs
    • Abzena Ltd
    • Northway Biotechpharma
    • Lonza Group Ltd
    • VIRUSURE
    • Selexis SA
    • Sigma-Aldrich
    • Takara Bio Inc

第22章 所使用的假设与缩写词

第23章 研究方法论

简介目录
Product Code: PMRREP31663

Persistence Market Research has recently released a comprehensive report on the worldwide market for mammalian cell banking. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Mammalian Cell Banking Market Size (2024E): USD 496.5 Million
  • Projected Market Value (2033F): USD 1600 Million
  • Global Market Growth Rate (CAGR 2024 to 2033): 13.9%

Mammalian Cell Banking Market - Report Scope:

Mammalian cell banking plays a crucial role in biopharmaceutical and biotechnology industries, providing a stable repository of cell lines for various applications, including drug development, vaccine production, and regenerative medicine. The market serves pharmaceutical companies, academic institutions, research laboratories, and contract research organizations (CROs), offering a range of services such as cell line characterization, storage, and distribution.

Market Growth Drivers:

The global mammalian cell banking market is driven by several key factors, including the increasing demand for biopharmaceuticals, rising investments in cell-based therapies, and advancements in biotechnology that enhance cell line stability and productivity. The growing prevalence of chronic diseases and the need for efficient production of biologics further propel market expansion. Moreover, technological innovations in cryopreservation techniques and quality control measures contribute to market growth by ensuring the integrity and viability of stored cell lines.

Market Restraints:

Despite promising growth prospects, the mammalian cell banking market faces challenges related to regulatory compliance, ethical considerations in cell line sourcing, and the complexity of maintaining cell line authenticity and purity over extended storage periods. Stringent regulations governing cell banking practices and the need for continuous monitoring to prevent contamination impose operational challenges on market players, affecting scalability and cost-efficiency.

Market Opportunities:

The mammalian cell banking market presents significant growth opportunities driven by emerging applications in personalized medicine, cell therapy, and stem cell research. The integration of automation and robotics in cell banking facilities enhances operational efficiency and reduces human error, thereby optimizing cell line management and storage. Furthermore, strategic collaborations between biopharmaceutical companies, academic institutions, and CROs facilitate knowledge exchange and accelerate innovation in cell banking technologies.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the mammalian cell banking market globally?
  • Which applications and therapeutic areas are driving demand for mammalian cell banking services?
  • How are technological advancements reshaping the competitive landscape of the mammalian cell banking market?
  • Who are the key players contributing to the mammalian cell banking market, and what strategies are they employing to maintain market leadership?
  • What are the emerging trends and future prospects in the global mammalian cell banking market?

Competitive Intelligence and Business Strategy:

Leading players in the global mammalian cell banking market, including Merck KGaA, Altogen Labs, and VIRUSURE, focus on innovation, expansion of service portfolios, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced cell banking solutions, including automated cryopreservation systems, cell line authentication technologies, and personalized medicine applications. Collaborations with regulatory agencies and industry stakeholders promote compliance with international quality standards and facilitate market access.

Key Companies Profiled:

  • Eurofins DiscoverX Corporation
  • Merck KGaA
  • Sartorius Stedim BioOutsource Limited.
  • Charles River Laboratories
  • Altogen Labs
  • Abzena Ltd
  • Northway Biotechpharma
  • Lonza Group Ltd
  • VIRUSURE
  • Selexis SA
  • Takara Bio Inc

Key Segments Covered in Manufacturing of Industry Research

Cell Type:

  • CHO
  • BHK
  • NS0
  • YB2/0 & P2/0
  • HEK293 & Derivatives
  • HELA

Technology:

  • TEP
  • IEP
  • SEP

Application:

  • MCB
  • WCB
  • EoP
  • R&D CB

End User:

  • Academic & Research Institute
  • Biopharmaceutical Companies
  • CROs

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply-Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Development/Innovation Trends

4. Key Success Factors

  • 4.1. Pipeline Assessment
  • 4.2. Value chain Analysis
  • 4.3. Key Promotional Strategies, By Key Manufacturers
  • 4.4. Regulatory Landscape
  • 4.5. PESTLE Analysis
  • 4.6. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure
    • 5.1.3. Global Cell Banking Outsourcing Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Key Player's Historic Growth
    • 5.2.2. Market Consolidation Activities
    • 5.2.3. Increasing Geriatric Population
    • 5.2.4. Rising Cases of Cancer
    • 5.2.5. Growing Preference of Mammalian Cell Banking
    • 5.2.6. Increased R&D investments by Government
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Cell
    • 6.1.2. By Technology
    • 6.1.3. By Application
    • 6.1.4. By End User
    • 6.1.5. By Region
  • 6.2. 2024 Market Scenario

7. Global Mammalian Cell Banking Market Demand Value or Size in (US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033, By Cell

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Cell, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Cell, 2024-2033
    • 8.3.1. CHO
    • 8.3.2. BHK
    • 8.3.3. NS0
    • 8.3.4. YB2/0 & P2/0
    • 8.3.5. HEK293 & Derivatives
    • 8.3.6. HELA
  • 8.4. Market Attractiveness Analysis By Cell

9. Global Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033, By Technology

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) By Technology, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2024-2033
    • 9.3.1. TEP
    • 9.3.2. IEP
    • 9.3.3. SEP
  • 9.4. Market Attractiveness Analysis By Technology

10. Global Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033, By Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2033
    • 10.3.1. MCB
    • 10.3.2. WCB
    • 10.3.3. EoP
    • 10.3.4. R&D CB
  • 10.4. Market Attractiveness Analysis By Application

11. Global Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) By End User, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2033
    • 11.3.1. Academic & Research Institute
    • 11.3.2. Biopharmaceutical Companies
    • 11.3.3. CROs
  • 11.4. Market Attractiveness Analysis By End User

12. Global Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2023
  • 12.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2024-2033
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. East Asia
    • 12.3.5. South Asia
    • 12.3.6. Oceania
    • 12.3.7. Middle East and Africa (MEA)
  • 12.4. Market Attractiveness Analysis By Region

13. North America Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
    • 13.3.2. By Cell
    • 13.3.3. By Technology
    • 13.3.4. By Application
    • 13.3.5. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Cell
    • 13.4.3. By Technology
    • 13.4.4. By End User
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. U.S. Mammalian Cell Banking Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Cell
        • 13.8.1.2.2. By Technology
        • 13.8.1.2.3. By Application
        • 13.8.1.2.4. By End User
    • 13.8.2. Canada Mammalian Cell Banking Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Cell
        • 13.8.2.2.2. By Technology
        • 13.8.2.2.3. By Application
        • 13.8.2.2.4. By End User

14. Latin America Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Mexico
      • 14.3.1.2. Brazil
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
    • 14.3.2. By Cell
    • 14.3.3. By Technology
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Cell
    • 14.4.3. By Technology
    • 14.4.4. By Application
    • 14.4.5. By End User
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Mexico Mammalian Cell Banking Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Cell
        • 14.8.1.2.2. By Technology
        • 14.8.1.2.3. By Application
        • 14.8.1.2.4. By End User
    • 14.8.2. Brazil Mammalian Cell Banking Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Cell
        • 14.8.2.2.2. By Technology
        • 14.8.2.2.3. By Application
        • 14.8.2.2.4. By End User
    • 14.8.3. Argentina Mammalian Cell Banking Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Cell
        • 14.8.3.2.2. By Technology
        • 14.8.3.2.3. By Application
        • 14.8.3.2.4. By End User

15. Europe Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Italy
      • 15.3.1.2. Germany
      • 15.3.1.3. U.K
      • 15.3.1.4. France
      • 15.3.1.5. Spain
      • 15.3.1.6. BENELUX
      • 15.3.1.7. Nordic Countries
      • 15.3.1.8. Russia
      • 15.3.1.9. Rest of Europe
    • 15.3.2. By Cell
    • 15.3.3. By Technology
    • 15.3.4. By Application
    • 15.3.5. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Cell
    • 15.4.3. By Technology
    • 15.4.4. By Application
    • 15.4.5. By End User
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Italy Mammalian Cell Banking Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Cell
        • 15.8.1.2.2. By Technology
        • 15.8.1.2.3. By Application
        • 15.8.1.2.4. By End User
    • 15.8.2. Germany Mammalian Cell Banking Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Cell
        • 15.8.2.2.2. By Technology
        • 15.8.2.2.3. By Application
        • 15.8.2.2.4. By End User
    • 15.8.3. U.K. Mammalian Cell Banking Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Cell
        • 15.8.3.2.2. By Technology
        • 15.8.3.2.3. By Application
        • 15.8.3.2.4. By End User
    • 15.8.4. France Mammalian Cell Banking Market Analysis
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Cell
        • 15.8.4.2.2. By Technology
        • 15.8.4.2.3. By Application
        • 15.8.4.2.4. By End User
    • 15.8.5. Spain Mammalian Cell Banking Market Analysis
      • 15.8.5.1. Introduction
      • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.5.2.1. By Cell
        • 15.8.5.2.2. By Technology
        • 15.8.5.2.3. By Application
        • 15.8.5.2.4. By End User
    • 15.8.6. BENELUX Mammalian Cell Banking Market Analysis
      • 15.8.6.1. Introduction
      • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.6.2.1. By Cell
        • 15.8.6.2.2. By Technology
        • 15.8.6.2.3. By Application
        • 15.8.6.2.4. By End User
    • 15.8.7. Nordic Countries Mammalian Cell Banking Market Analysis
      • 15.8.7.1. Introduction
      • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.7.2.1. By Cell
        • 15.8.7.2.2. By Technology
        • 15.8.7.2.3. By Application
        • 15.8.7.2.4. By End User
    • 15.8.8. Russia Mammalian Cell Banking Market Analysis
      • 15.8.8.1. Introduction
      • 15.8.8.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.8.2.1. By Cell
        • 15.8.8.2.2. By Technology
        • 15.8.8.2.3. By Application
        • 15.8.8.2.4. By End User

16. South Asia Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Cell
    • 16.3.3. By Technology
    • 16.3.4. By Application
    • 16.3.5. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Cell
    • 16.4.3. By Technology
    • 16.4.4. By Application
    • 16.4.5. By End User
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. India Mammalian Cell Banking Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Cell
        • 16.8.1.2.2. By Technology
        • 16.8.1.2.3. By Application
        • 16.8.1.2.4. By End User
    • 16.8.2. Indonesia Mammalian Cell Banking Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Cell
        • 16.8.2.2.2. By Technology
        • 16.8.2.2.3. By Application
        • 16.8.2.2.4. By End User
    • 16.8.3. Malaysia Mammalian Cell Banking Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Cell
        • 16.8.3.2.2. By Technology
        • 16.8.3.2.3. By Application
        • 16.8.3.2.4. By End User
    • 16.8.4. Thailand Mammalian Cell Banking Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Cell
        • 16.8.4.2.2. By Technology
        • 16.8.4.2.3. By Application
        • 16.8.4.2.4. By End User

17. East Asia Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Cell
    • 17.3.3. By Technology
    • 17.3.4. By Application
    • 17.3.5. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Cell
    • 17.4.3. By Technology
    • 17.4.4. By Application
    • 17.4.5. By End User
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. China Mammalian Cell Banking Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Cell
        • 17.8.1.2.2. By Technology
        • 17.8.1.2.3. By Application
        • 17.8.1.2.4. By End User
    • 17.8.2. Japan Mammalian Cell Banking Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Cell
        • 17.8.2.2.2. By Technology
        • 17.8.2.2.3. By Application
        • 17.8.2.2.4. By End User
    • 17.8.3. South Korea Mammalian Cell Banking Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Cell
        • 17.8.3.2.2. By Technology
        • 17.8.3.2.3. By Application
        • 17.8.3.2.4. By End User

18. Oceania Mammalian Cell Banking Market 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. Australia
      • 18.3.1.2. New Zealand
    • 18.3.2. By Cell
    • 18.3.3. By Technology
    • 18.3.4. By Application
    • 18.3.5. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Cell
    • 18.4.3. By Technology
    • 18.4.4. By Application
    • 18.4.5. By End User
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. Australia Mammalian Cell Banking Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Cell
        • 18.8.1.2.2. By Technology
        • 18.8.1.2.3. By Application
        • 18.8.1.2.4. By End User
    • 18.8.2. New Zealand Mammalian Cell Banking Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Cell
        • 18.8.2.2.2. By Technology
        • 18.8.2.2.3. By Application
        • 18.8.2.2.4. By End User

19. Middle East and Africa (MEA) Mammalian Cell Banking Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. GCC Countries
      • 19.3.1.2. Turkey
      • 19.3.1.3. South Africa
      • 19.3.1.4. North Africa
      • 19.3.1.5. Rest of Middle East and Africa
    • 19.3.2. By Cell
    • 19.3.3. By Technology
    • 19.3.4. By Application
    • 19.3.5. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Cell
    • 19.4.3. By Technology
    • 19.4.4. By Application
    • 19.4.5. By End User
  • 19.5. Market Trends
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. GCC Countries Mammalian Cell Banking Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Cell
        • 19.8.1.2.2. By Technology
        • 19.8.1.2.3. By Application
        • 19.8.1.2.4. By End User
    • 19.8.2. Turkey Mammalian Cell Banking Market Analysis
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Cell
        • 19.8.2.2.2. By Technology
        • 19.8.2.2.3. By Application
        • 19.8.2.2.4. By End User
    • 19.8.3. South Africa Mammalian Cell Banking Market Analysis
      • 19.8.3.1. Introduction
      • 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.3.2.1. By Cell
        • 19.8.3.2.2. By Technology
        • 19.8.3.2.3. By Application
        • 19.8.3.2.4. By End User
    • 19.8.4. North Africa Mammalian Cell Banking Market Analysis
      • 19.8.4.1. Introduction
      • 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.4.2.1. By Cell
        • 19.8.4.2.2. By Technology
        • 19.8.4.2.3. By Application
        • 19.8.4.2.4. By End User

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies
  • 20.2. Market Share Analysis of Top Players (%)
  • 20.3. Market Presence Analysis
    • 20.3.1. By Regional Footprint of Players
    • 20.3.2. Cell Footprint of Players
    • 20.3.3. Channel Footprint of Players

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Competition Benchmarking
  • 21.3. Competition Deep Dive
    • 21.3.1. Eurofins DiscoverX Corporation
      • 21.3.1.1. Overview
      • 21.3.1.2. Product & Services Portfolio
      • 21.3.1.3. Key Financials
      • 21.3.1.4. SWOT Analysis
      • 21.3.1.5. Key Developments
      • 21.3.1.6. Sales Footprint
      • 21.3.1.7. Strategy Overview
        • 21.3.1.7.1. Marketing Strategy
        • 21.3.1.7.2. Product Strategy
        • 21.3.1.7.3. Channel Strategy
    • 21.3.2. Merck KGaA
      • 21.3.2.1. Overview
      • 21.3.2.2. Product & Services Portfolio
      • 21.3.2.3. Key Financials
      • 21.3.2.4. SWOT Analysis
      • 21.3.2.5. Key Developments
      • 21.3.2.6. Sales Footprint
      • 21.3.2.7. Strategy Overview
        • 21.3.2.7.1. Marketing Strategy
        • 21.3.2.7.2. Product Strategy
        • 21.3.2.7.3. Channel Strategy
    • 21.3.3. Sartorius Stedim BioOutsource Limited.
      • 21.3.3.1. Overview
      • 21.3.3.2. Product & Services Portfolio
      • 21.3.3.3. Key Financials
      • 21.3.3.4. SWOT Analysis
      • 21.3.3.5. Key Developments
      • 21.3.3.6. Sales Footprint
      • 21.3.3.7. Strategy Overview
        • 21.3.3.7.1. Marketing Strategy
        • 21.3.3.7.2. Product Strategy
        • 21.3.3.7.3. Channel Strategy
    • 21.3.4. Charles River Laboratories
      • 21.3.4.1. Overview
      • 21.3.4.2. Product & Services Portfolio
      • 21.3.4.3. Key Financials
      • 21.3.4.4. SWOT Analysis
      • 21.3.4.5. Key Developments
      • 21.3.4.6. Sales Footprint
      • 21.3.4.7. Strategy Overview
        • 21.3.4.7.1. Marketing Strategy
        • 21.3.4.7.2. Product Strategy
        • 21.3.4.7.3. Channel Strategy
    • 21.3.5. Altogen Labs
      • 21.3.5.1. Overview
      • 21.3.5.2. Product & Services Portfolio
      • 21.3.5.3. Key Financials
      • 21.3.5.4. SWOT Analysis
      • 21.3.5.5. Key Developments
      • 21.3.5.6. Sales Footprint
      • 21.3.5.7. Strategy Overview
        • 21.3.5.7.1. Marketing Strategy
        • 21.3.5.7.2. Product Strategy
        • 21.3.5.7.3. Channel Strategy
    • 21.3.6. Abzena Ltd
      • 21.3.6.1. Overview
      • 21.3.6.2. Product & Services Portfolio
      • 21.3.6.3. Key Financials
      • 21.3.6.4. SWOT Analysis
      • 21.3.6.5. Key Developments
      • 21.3.6.6. Sales Footprint
      • 21.3.6.7. Strategy Overview
        • 21.3.6.7.1. Marketing Strategy
        • 21.3.6.7.2. Product Strategy
        • 21.3.6.7.3. Channel Strategy
    • 21.3.7. Northway Biotechpharma
      • 21.3.7.1. Overview
      • 21.3.7.2. Product & Services Portfolio
      • 21.3.7.3. Key Financials
      • 21.3.7.4. SWOT Analysis
      • 21.3.7.5. Key Developments
      • 21.3.7.6. Sales Footprint
      • 21.3.7.7. Strategy Overview
        • 21.3.7.7.1. Marketing Strategy
        • 21.3.7.7.2. Product Strategy
        • 21.3.7.7.3. Channel Strategy
    • 21.3.8. Lonza Group Ltd
      • 21.3.8.1. Overview
      • 21.3.8.2. Product & Services Portfolio
      • 21.3.8.3. Key Financials
      • 21.3.8.4. SWOT Analysis
      • 21.3.8.5. Key Developments
      • 21.3.8.6. Sales Footprint
      • 21.3.8.7. Strategy Overview
        • 21.3.8.7.1. Marketing Strategy
        • 21.3.8.7.2. Product Strategy
        • 21.3.8.7.3. Channel Strategy
    • 21.3.9. VIRUSURE
      • 21.3.9.1. Overview
      • 21.3.9.2. Product & Services Portfolio
      • 21.3.9.3. Key Financials
      • 21.3.9.4. SWOT Analysis
      • 21.3.9.5. Key Developments
      • 21.3.9.6. Sales Footprint
      • 21.3.9.7. Strategy Overview
        • 21.3.9.7.1. Marketing Strategy
        • 21.3.9.7.2. Product Strategy
        • 21.3.9.7.3. Channel Strategy
    • 21.3.10. Selexis SA
      • 21.3.10.1. Overview
      • 21.3.10.2. Product & Services Portfolio
      • 21.3.10.3. Key Financials
      • 21.3.10.4. SWOT Analysis
      • 21.3.10.5. Key Developments
      • 21.3.10.6. Sales Footprint
      • 21.3.10.7. Strategy Overview
        • 21.3.10.7.1. Marketing Strategy
        • 21.3.10.7.2. Product Strategy
        • 21.3.10.7.3. Channel Strategy
    • 21.3.11. Sigma-Aldrich
      • 21.3.11.1. Overview
      • 21.3.11.2. Product & Services Portfolio
      • 21.3.11.3. Key Financials
      • 21.3.11.4. SWOT Analysis
      • 21.3.11.5. Key Developments
      • 21.3.11.6. Sales Footprint
      • 21.3.11.7. Strategy Overview
        • 21.3.11.7.1. Marketing Strategy
        • 21.3.11.7.2. Product Strategy
        • 21.3.11.7.3. Channel Strategy
    • 21.3.12. Takara Bio Inc
      • 21.3.12.1. Overview
      • 21.3.12.2. Product & Services Portfolio
      • 21.3.12.3. Key Financials
      • 21.3.12.4. SWOT Analysis
      • 21.3.12.5. Key Developments
      • 21.3.12.6. Sales Footprint
      • 21.3.12.7. Strategy Overview
        • 21.3.12.7.1. Marketing Strategy
        • 21.3.12.7.2. Product Strategy
        • 21.3.12.7.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology